Showing 1 - 3 results of 3 for search 'Jeffrey J Swigris', query time: 0.01s Refine Results
  1. 1
    Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?

    Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how? by Jeffrey J Swigris, Kerri Aronson, Susan S Jacobs, Dawn Repola

    Published 2023-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Reliability and responsiveness of the D12 and validity of its scores as a measure of dyspnoea severity in patients with rheumatoid arthritis-related interstitial lung disease

    Reliability and responsiveness of the D12 and validity of its scores as a measure of dyspnoea severity in patients with rheumatoid arthritis-related interstitial lung disease by Jeffrey J Swigris, Sonye Danoff, Paul F Dellaripa, Joshua J Solomon, Tracy J Doyle

    Published 2023-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)

    Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial... by Jeffrey J Swigris, Toby M Maher, Tamera J Corte, Aryeh Fischer, Hong Xiao, Lisa Lancaster, Takafumi Suda, Xiaojiang Zhan, Jonathan G Goldin, Scott M Palmer, Hideaki Watanabe, Takashi Ogura, Anne Minnich, Giridhar S Tirucherai, Brandon Elpers, R Adam Smith, Edgar D Charles

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: